WLSH logo
 

Health Professionals Guide to Newborn Screening

Homocystinuria & Hypermethioninemia

Autosomal recessive amino acid disorder caused primarily by a deficiency in cystathionine beta synthase enzyme activity causing the build up of the amino acid methionine in the blood. Early detection and treatment can prevent associated mental retardation, seizures, motor development delays, weakening of bones, and venous and arterial blood clots.

Prevalence (WI): 1:119,000 (general population)
Analyte Measured: Methionine
Abnormal Levels: ³ 100 µmol/L
Feeding Effect: None
Timing Effect: < 24 hours of age: Repeat at two weeks
³ 24 hours of age: Results are valid
Confirmation: Immediate consult with a metabolic specialist at a metabolic treatment center.

Treatment:

The treatment for homocystinuria is the dietary restriction of methionine as well as large doses of vitamin B6 and betaine.

Information on treatment centers is also available on this site.


For information about other screened disorders, click on the next page button, or follow one of these links:

Argininosuccinic Acidemia (ASA) Hemoglobin Variants
Biotinidase Deficiency Homocystinuria
Congenital Adrenal Hyperplasia Hypermethioninemia
Congenital Hypothyroidism Hyperphenyalaninemia
Citrullinemia (Types I & II) Maple Syrup Urine Disease
Cystic Fibrosis Organic Acidemias (14)

Fatty Acid Oxidation Disorders (12)

 

Phenylketonuria
(Includes Biopterin Cofactor defects
of regeneration and biosynthesis)

Galactosemia Severe Combined Immune Deficiency (SCID)
Hemoglobin S-Beta Thallassemia Sickle Cell Disease
Hemoglobin S/C Disease Tyrosinemia (Types I,II, & III)

NEXT PAGE

 

Feedback, questions or accessibility issues: nbsinfo@mail.slh.wisc.edu

The Wisconsin Newborn Screening Laboratory
465 Henry Mall
Madison WI 53706
Phone: (608) 262-6547
Fax: (608) 262-5494

Wisconsin State Laboratory of Hygiene
Copyright © 2003 The Board of Regents of the University of Wisconsin System.
Locations | Contact | Legal Notices | Acceptable Use | Privacy Policy